We are live on ! Find out more
TRIM

Thompson Rubinstein Investment Management Portfolio holdings

AUM $311M
1-Year Est. Return 11.71%
This Fund
S&P 500
This Quarter Est. Return
+3.26%
1 Year Est. Return
+11.71%
3 Year Est. Return
+42.81%
5 Year Est. Return
+48.65%
10 Year Est. Return
AUM
$257M
AUM Growth
+$11.7M
Cap. Flow
+$5.42M
Cap. Flow %
2.11%
Top 10 Hldgs %
38.42%
Holding
78
New
1
Increased
26
Reduced
18
Closed

Top Sells

Rank Stock Value
1
DVN icon
Devon Energy
DVN
+$882K
2
VZ icon
Verizon
VZ
+$77.8K
3
HD icon
Home Depot
HD
+$66.1K
4
SPXC icon
SPX Corp
SPXC
+$64.1K
5
DO
Diamond Offshore Drilling
DO
+$63.3K

Sector Composition

Rank Sector Weight
1 Healthcare 27.82%
2 Industrials 21.56%
3 Technology 14.53%
4 Energy 12.91%
5 Consumer Staples 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SVU
51
DELISTED
SUPERVALU Inc.
SVU
$1.25M 0.49%
37,894
USB icon
52
US Bancorp
USB
$99.6B
$1.2M 0.47%
29,821
STT icon
53
State Street
STT
$50.7B
$1.14M 0.44%
21,174
-150
-0.7% -$8.96K
DVN icon
54
Devon Energy
DVN
$47.6B
$1.05M 0.41%
28,902
-26,021
-47% -$882K
KEYS icon
55
Keysight
KEYS
$58.3B
$1.03M 0.4%
35,290
-125
-0.4% -$3.54K
CAT icon
56
Caterpillar
CAT
$388B
$948K 0.37%
12,508
+550
+5% +$41.2K
STR
57
DELISTED
QUESTAR CORP
STR
$878K 0.34%
34,600
-670
-2% -$16.8K
TRV icon
58
Travelers Companies
TRV
$80B
$747K 0.29%
6,279
FLOW
59
DELISTED
SPX FLOW, Inc.
FLOW
$736K 0.29%
28,222
-2,038
-7% -$58K
MRK icon
60
Merck
MRK
$316B
$717K 0.28%
13,036
+377
+3% +$20.1K
BMY icon
61
Bristol-Myers Squibb
BMY
$131B
$706K 0.27%
9,600
AGN
62
DELISTED
Allergan plc
AGN
$681K 0.27%
+2,946
New +$679K
JCI icon
63
Johnson Controls International
JCI
$93.8B
$605K 0.24%
13,064
SPXC icon
64
SPX Corp
SPXC
$10.8B
$597K 0.23%
40,227
-4,045
-9% -$64.1K
CDK
65
DELISTED
CDK Global, Inc.
CDK
$593K 0.23%
10,694
JPM icon
66
JPMorgan Chase
JPM
$948B
$511K 0.2%
8,220
MRSH
67
Marsh
MRSH
$91.3B
$502K 0.2%
7,327
+465
+7% +$29.9K
ED icon
68
Consolidated Edison
ED
$39.8B
$500K 0.19%
6,219
-600
-9% -$45.1K
FEIC
69
DELISTED
FEI COMPANY
FEIC
$477K 0.19%
4,464
-311
-7% -$29.7K
EW icon
70
Edwards Lifesciences
EW
$51.8B
$400K 0.16%
12,030
COLM icon
71
Columbia Sportswear
COLM
$2.92B
$386K 0.15%
6,716
RTX icon
72
RTX Corp
RTX
$299B
$328K 0.13%
5,085
ORCL icon
73
Oracle
ORCL
$420B
$323K 0.13%
7,900
LVLT
74
DELISTED
Level 3 Communications Inc
LVLT
$307K 0.12%
5,956
WST icon
75
West Pharmaceutical
WST
$24.9B
$304K 0.12%
4,000

Similar funds

Thompson Rubinstein Investment Management's Q2 2016 Portfolio in Review

As of Q2 2016, Thompson Rubinstein Investment Management held 78 positions worth $257M, up 4.8% from $245M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Trading was light in Q2 2016: portfolio turnover was 1.3%. Thompson Rubinstein Investment Management opened 1 new position and made no exits, leaving the 78-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Industrials and Technology.

  • Thompson Rubinstein Investment Management's largest Q2 2016 buy was Allergan plc: 2,946 shares worth $681K.
  • Thompson Rubinstein Investment Management added most to Biogen in Q2 2016, an estimated $1.36M increase.
  • Thompson Rubinstein Investment Management's biggest Q2 2016 reduction was Devon Energy, cutting an estimated $882K.
  • Thompson Rubinstein Investment Management's ten largest holdings make up 38% of its $257M portfolio in Q2 2016.
  • Thompson Rubinstein Investment Management opened 1 new position and closed 0 in Q2 2016.
  • Thompson Rubinstein Investment Management's portfolio value rose 4.8% quarter-over-quarter to $257M.

Based on Thompson Rubinstein Investment Management's 13F filing for Q2 2016, filed 8 Jul 2016.